FRANKFURT (dpa-AFX) – Solid figures from the diagnostics and biotechnology group Danaher were well received on the German stock market on Tuesday. With the shares of Merck KGaA (Merck) and Sartorius (Sartorius vz), two securities in the industry reacted positively to the US company’s figures.
While Merck KGaA rose by 2.1 percent in the DAX, Sartorius rose by 4.4 percent in the MDAX. Prices rose by 2.2 percent in the US premarket.
Danaher, with a market value of almost 140 billion US dollars, was significantly more profitable in the first quarter than expected. The adjusted operating margin was 30.2 percent, above the consensus estimate of 28.3 percent. With a view to adjusted earnings per share in the current second quarter, Danaher also became somewhat more optimistic than before./bek/jha/
By the way: Danaher and other US stocks can even be traded on finanzen.net ZERO until 11 p.m. (without order fees, plus spreads). Open a depot now for free and secure a new customer bonus!
Selected leverage products on Danaher
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Danaher
The leverage must be between 2 and 20
Advertising
